Cancer stem cells, cancer-initiating cells and methods for their detection

Drug Discovery Today

Volumn 21, Issue 5, 2016, Pages 836-842

  Akbari Birgani, Shiva ^a   Paranjothy, Ted ^b   Zuse, Anna ^c   Janikowski, Tomasz ^d   Cieślar Pobuda, Artur ^e   Likus, Wirginia ^f   Urasińska, Elzbieta ^g   Schweizer, Frank ^h   Ghavami, Saeid ^h,j   Klonisch, Thomas ^h   Łos, Marek J ^f,i  

^a INSTITUTE FOR ADVANCED STUDIES IN BASIC SCIENCES IASBS   (Iran)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF SILESIA   (Poland)

^e SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g POMERANIAN MEDICAL UNIVERSITY   (Poland)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ LinkoCare Life Sciences AB   (Sweden)

^j SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

more..

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE F 18; ABC TRANSPORTER B5; ANTIBODY; CD133 ANTIGEN; CONTRAST MEDIUM; ENHANCED GREEN FLUORESCENT PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; FERRITIN; FIREFLY LUCIFERASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 5; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; IODINE 125; LUCIFERASE; NESTIN; PROTEASOME; QUANTUM DOT; RED FLUORESCENT PROTEIN; TRACER; TRANSCRIPTION FACTOR HES 1; TUMOR MARKER; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

BIOLUMINESCENCE; BRAIN CANCER; BREAST ADENOMA; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER INITIATING CELL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SUBPOPULATION; COLON CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; ECHOGRAPHY; FLUORESCENCE IMAGING; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MEDULLOBLASTOMA; MELANOMA; METASTASIS; MOLECULAR IMAGING; MULTIMODAL IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL SELF-RENEWAL; TREATMENT FAILURE; ANIMAL; CARCINOGENESIS;

ANIMALS; CARCINOGENESIS; HUMANS; MOLECULAR IMAGING; NEOPLASTIC STEM CELLS;

EID: 84961786472     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.03.004     Document Type: Review

References (98)

1. M.R. Junttila, and F.J. de Sauvage Influence of tumour micro-environment heterogeneity on therapeutic response Nature 501 2013 346 354
2. F. Michor, and K. Polyak The origins and implications of intratumor heterogeneity Cancer Prev. Res. 3 2010 1361 1364
3. M. Greaves, and C.C. Maley Clonal evolution in cancer Nature 481 2012 306 313
4. B. Beck, and C. Blanpain Unravelling cancer stem cell potential Nat. Rev. Cancer 13 2013 727 738
5. L.V. Nguyen, and et al. Cancer stem cells: an evolving concept Nat. Rev. Cancer 12 2012 133 143
6. M. Shackleton, and et al. Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 2009 822 829
7. M. Askanazy Die Teratome nach ihrem Bau, ihrem Verlauf ihrer Genese und im Vergleich zum experimentellen Teratoid Verhandl. Deutsch. Pathol. 11 1907 120 Author reply 121 (in German)
8. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 3 1997 730 737
9. A. Cieslar-Pobuda, and et al. The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells Oncotarget 6 2015 29753 29770
10. E. Farahani, and et al. Cell adhesion molecules and their relation to (cancer) cell stemness Carcinogenesis 35 2014 747 759
11. A.M. Wasik, and et al. Reprogramming and carcinogenesis - parallels and distinctions Int. Rev. Cell Mol. Biol. 308 2014 167 203
12. J.J. Kim, and I.F. Tannock Repopulation of cancer cells during therapy: an important cause of treatment failure Nat. Rev. Cancer 5 2005 516 525
13. M. Cojoc, and et al. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms Semin. Cancer Biol. 31 2015 16 27
14. R. Bjerkvig, and et al. Opinion: the origin of the cancer stem cell: current controversies and new insights Nat. Rev. Cancer 5 2005 899 904
15. P. Scaffidi, and T. Misteli In vitro generation of human cells with cancer stem cell properties Nat. Cell Biol. 13 2011 1051 1061
16. K. Chen, and et al. Understanding and targeting cancer stem cells: therapeutic implications and challenges Acta Pharmacol. Sin. 34 2013 732 740
17. Y. Hu, and L. Fu Targeting cancer stem cells: a new therapy to cure cancer patients Am. J. Cancer Res. 2 2012 340 356
18. M. Rahman, and et al. The cancer stem cell hypothesis: failures and pitfalls Neurosurgery 68 2011 531 545 (discussion 545)
19. D. Tseng, and et al. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response Proc. Natl. Acad. Sci. U. S. A. 110 2013 11103 11108
20. T.C. Somervaille, and M.L. Cleary Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Cancer Cell 10 2006 257 268
21. H.J. Snippert, and H. Clevers Tracking adult stem cells EMBO Rep. 12 2011 113 122
22. A. Golebiewska, and et al. Critical appraisal of the side population assay in stem cell and cancer stem cell research Cell Stem Cell 8 2011 136 147
23. P. Marcato, and et al. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform Cell Cycle 10 2011 1378 1384
24. T. Klonisch, and et al. Cancer stem cell markers in common cancers - therapeutic implications Trends Mol. Med. 14 2008 450 460
25. J.P. Medema Cancer stem cells: the challenges ahead Nat. Cell Biol. 15 2013 338 344
26. L.D. Shultz, and C.L. Sidman Genetically determined murine models of immunodeficiency Annu. Rev. Immunol. 5 1987 367 403
27. T. Sakakibara, and et al. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice Cancer J. Sci. Am. 2 1996 291 300
28. M. Al-Hajj, and et al. Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 3983 3988
29. T.A. Read, and et al. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma Cancer Cell 15 2009 135 147
30. L.V. Goodrich, and et al. Altered neural cell fates and medulloblastoma in mouse patched mutants Science 277 1997 1109 1113
31. A.G. Schepers, and et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas Science 337 2012 730 735
32. K.A. Klein, and et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice Nat. Med. 3 1997 402 408
33. T. Nickerson, and et al. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR) Cancer Res. 61 2001 6276 6280
34. R.E. Reiter, and et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer Proc. Natl. Acad. Sci. U. S. A. 95 1998 1735 1740
35. L. Patrawala, and et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 2006 1696 1708
36. C. Li, and et al. Identification of pancreatic cancer stem cells Cancer Res. 67 2007 1030 1037
37. H. Liu, and et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models Proc. Natl. Acad. Sci. U. S. A. 107 2010 18115 18120
38. M. Shahali, and et al. A novel in vitro model for cancer stem cell culture using ectopically expressed piwil2 stable cell line Cell J. 15 2013 250 257
39. A. Cieslar-Pobuda, and et al. Cell type related differences in staining with pentameric thiophene derivatives Cytometry A 85 2014 628 635
40. K. Magnusson, and et al. Differential vital staining of normal fibroblasts and melanoma cells by an anionic conjugated polyelectrolyte Cytometry A 87 2015 262 272
41. D.A. Mankoff A definition of molecular imaging J. Nucl. Med. 48 2007 18N, 21N
42. K. Shah, and et al. Molecular imaging of gene therapy for cancer Gene Ther. 11 2004 1175 1187
43. Y. Amoh, and et al. Color-coded fluorescent protein imaging of angiogenesis: the AngioMouse models Curr. Pharm. Des. 14 2008 3810 3819
44. K. Yamauchi, and et al. Color-coded real-time subcellular fluorescence imaging of the interaction between cancer and host cells in live mice Anticancer Res. 32 2012 39 43
45. R.M. Hoffman, and M. Yang Dual-color, whole-body imaging in mice Nat. Biotechnol. 23 2005 790 Author reply 791
46. M. Bruchez Jr., and et al. Semiconductor nanocrystals as fluorescent biological labels Science 281 1998 2013 2016
47. M.K. So, and et al. Self-illuminating quantum dot conjugates for in vivo imaging Nat. Biotechnol. 24 2006 339 343
48. J.A. Prescher, and C.H. Contag Guided by the light: visualizing biomolecular processes in living animals with bioluminescence Curr. Opin. Chem. Biol. 14 2010 80 89
49. A.M. Loening, and et al. Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output Protein Eng. Des. Sel. 19 2006 391 400
50. D.M. Close, and et al. In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals Sensors 11 2011 180 206
51. B.P. Joshi, and T.D. Wang Exogenous molecular probes for targeted imaging in cancer: focus on multi-modal imaging Cancers 2 2010 1251 1287
52. J. Condeelis, and R. Weissleder In vivo imaging in cancer Cold Spring Harb. Perspect. Biol. 2 2010 a003848
53. T. Reuveni, and et al. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study Int. J. Nanomed. 6 2011 2859 2864
54. M.E. Van Dort, and et al. PET and SPECT imaging of tumor biology: new approaches towards oncology drug discovery and development Curr. Comput. Aided Drug Des. 4 2008 46 53
55. Y.X. Wang Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application Quant. Imaging Med. Surg. 1 2011 35 40
56. Q. He, and et al. Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment Dis. Markers 19 2003 69 94
57. V. Ponomarev, and et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging Eur. J. Nucl. Med. Mol. Imaging 31 2004 740 751
58. Y.D. Heryanto, and et al. In vivo molecular imaging of cancer stem cells Am. J. Nucl. Med. Mol. Imaging 5 2015 14 26
59. H. Hong, and et al. Non-invasive cell tracking in cancer and cancer therapy Curr. Top. Med. Chem. 10 2010 1237 1248
60. V. Ponomarev Nuclear imaging of cancer cell therapies J. Nucl. Med. 50 2009 1013 1016
61. E. Vlashi, and et al. In vivo imaging, tracking, and targeting of cancer stem cells J. Natl. Cancer Inst. 101 2009 350 359
62. S. Beck, and et al. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells Biomaterials 32 2011 8518 8528
63. T. Schatton, and et al. Identification of cells initiating human melanomas Nature 451 2008 345 349
64. S. Gaedicke, and et al. Noninvasive positron emission tomography and fluorescence imaging of CD133+ tumor stem cells Proc. Natl. Acad. Sci. U. S. A. 111 2014 E692 E701
65. R. McClelland, and et al. In situ labeling and magnetic resonance imaging of transplanted human hepatic stem cells Mol. Imaging Biol. 13 2011 911 922
66. Z.H. Jin, and et al. Basic studies on radioimmunotargeting of CD133-positive HCT116 cancer stem cells Mol. Imaging 11 2012 445 450
67. Y. Choi, and et al. Noninvasive identification of viable cell populations in docetaxel-treated breast tumors using ferritin-based magnetic resonance imaging PLOS ONE 8 2013 e52931
68. A. Cieslar-Pobuda, and M.J. Los Prospects and limitations of 'Click-Chemistry'-based DNA labeling technique employing 5-ethynyl-2′deoxyuridine (EdU) Cytometry A 83 2013 977 978
69. S. Hombach-Klonisch, and et al. Cancer stem cells as targets for cancer therapy: selected cancers as examples Arch. Immunol. Ther. Exp. 56 2008 165 180
70. J.R. Jangamreddy, and et al. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells Biochim. Biophys. Acta 1833 2013 2057 2069
71. W. Chaabane, and et al. Human-gyrovirus-Apoptin triggers mitochondrial death pathway - Nur77 is required for apoptosis triggering Neoplasia 16 2014 679 693
72. O.M. Rollano Penaloza, and et al. Apoptins: selective anticancer agents Trends Mol. Med. 20 2014 519 528
73. W. Chaabane, and et al. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer Arch. Immunol. Ther. Exp. 61 2013 43 58
74. W. Likus, and et al. Could drugs inhibiting the mevalonate pathway also target cancer stem cells? Drug Resist. Updates 25 2016 13 25
75. + cells with cancer stem cell characteristics Breast Cancer Res. 10 2008 R10
76. S. Ricardo, and et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype J. Clin. Pathol. 64 2011 937 946
77. H.L. Goel, and et al. GLI1 regulates a novel neuropilin-2/alpha6beta1 integrin based autocrine pathway that contributes to breast cancer initiation EMBO Mol. Med. 5 2013 488 508
78. X.G. Mao, and et al. Brain tumor stem-like cells identified by neural stem cell marker CD15 Transl. Oncol. 2 2009 247 257
79. J.D. Lathia, and et al. Integrin alpha 6 regulates glioblastoma stem cells Cell Stem Cell 6 2010 421 432
80. A.G. Vaiopoulos, and et al. Colorectal cancer stem cells Stem Cells 30 2012 363 371
81. S.M. Sureban, and et al. DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism Cancer Res. 71 2011 2328 2338
82. M.P. Kim, and et al. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma PLoS ONE 6 2011 e20636
83. T. Schatton, and M.H. Frank Cancer stem cells and human malignant melanoma Pigment Cell Melanoma Res. 21 2008 39 55
84. G. Civenni, and et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth Cancer Res. 71 2011 3098 3109
85. Y. Luo, and et al. Isolation of human melanoma stem cells using ALDH as a marker Curr. Protoc. Stem Cell Biol. 26 2013 10.1002/9780470151808.sc0308s26
86. A.K. Templeton, and et al. Cancer stem cells: progress and challenges in lung cancer Stem Cell Investig. 2014 10.3978/j.issn.2306-9759.2014.03.06
87. J. Pan, and et al. 26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro PLoS ONE 5 2010 e13298
88. T. Yamashita, and X.W. Wang Cancer stem cells in the development of liver cancer J. Clin. Invest. 123 2013 1911 1918
89. L. Patrawala, and et al. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells Cancer Res. 67 2007 6796 6805
90. G.D. Richardson, and et al. CD133, a novel marker for human prostatic epithelial stem cells J. Cell Sci. 117 2004 3539 3545
91. J. Jiao, and et al. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells PLoS ONE 7 2012 e42564
92. A. Matsika, and et al. Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2 Pathology 47 2015 622 628
93. A.S. Goldstein, and et al. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics Proc. Natl. Acad. Sci. U. S. A. 105 2008 20882 20887
94. I.A. Silva, and et al. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res. 71 2011 3991 4001
95. S.J. Horton, and B.J. Huntly Recent advances in acute myeloid leukemia stem cell biology Haematologica 97 2012 966 974
96. J. Han, and et al. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma BMC Cancer 14 2014 173
97. S.K. Singh, and et al. Identification of human brain tumour initiating cells Nature 432 2004 396 401
98. L. Garzia, and et al. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma PLoS ONE 4 2009 e4998